Ocular toxoplasmosis. An overview during pregnancy
DOI:
https://doi.org/10.35319/conr.20202238Keywords:
Prevalence, toxoplasmosis, congenital transmission, seroprevalence, chorioretinitisAbstract
Toxoplasmosis is a disease caused by the protozoan T. gondii, which affects a third of the world's population. According to WHO data, these figures are not updated. The consumption of infective oocysts that are found in the inadequate handling and ingestion of foods such as raw or undercooked meat, contaminated vegetables, or water with the presence of oocysts, the increase in the prevalence in our country, Latin America, and the Caribbean that contributes On the development of this disease it is acquired congenitally in pregnant women, in ocular toxoplasmosis, the parasite lodges in the retina causing retinitis. It manifests itself at any age, after birth the infection can be acute or chronic. It can be said that, with the passage of each gestational week, the risk of maternal-fetal transmission will increase, therefore the probability of asymptomatic congenital toxoplasmosis increases. Diagnosis during pregnancy should be carried out, in order to establish whether the fetus is infected, by means of the diagnosis of amniotic fluid (amniocentesis), histological, and ultrasound. Treatment in pregnant women could reduce the incidence and severity of the fetal infection.
Downloads
References
Dodds EM, Toxoplasmosis Ocular. Arch Soc Esp Oftamol 2003;78(10):531-41. DOI: https://doi.org/10.4321/S0365-66912003001000004
Furtado JM, Smith JR, Belfort R, Gattey D, Winthrop K. Toxoplasmosis: una amenaza global. J Glob Infect Dis 2011;3(3):281-4. DOI: https://doi.org/10.4103/0974-777X.83536
Commodaro AG, Belfort RN, Rizzo LV, Muccioli C, Silveira C, Burnier MN, et al. Toxoplasmosis ocular: una actualización y revisión de la literatura. Mem Inst Oswaldo Cruz 2009;104(2):345-50. DOI: https://doi.org/10.1590/S0074-02762009000200030
Holland GN, Edward LX. Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of the disease. Am J Ophthalmol 2003;136(6):973-88. DOI: https://doi.org/10.1016/j.ajo.2003.09.040
Silveira C, Belford RJ, Burnier MJ, Nussenblatt R. Acquired toxoplasmic infection as the cause of toxoplasmic retino choroiditis in families. Am J Ophthalmol 1988;106(3):362-4. DOI: https://doi.org/10.1016/10.1016/0002-9394(88)90382-0
Guerra C, Fernández J. Seroprevalencia del Toxoplasma gondii en gestantes. Aten Primaria 1996;16:151-3. DOI: http://doi.org/10.1016/j.oftal.2010.07.001
Glasner PD, Silveira C, Kruszon MD, Martins MC, Burnier JM, Silveira S, et al. An usually high prevalence of ocular toxoplasmosis in southern Brazil. Am J Ofhthalmol 1992;114(2):136-44. DOI: http://doi.org/10.1016/s00029394(14)73976-5
Guzmán A, Núñez LE, Vargas JL, Mendoza M, Galarza E, Roca Y, et al. Seroprevalencia de toxoplasmosis y factores asociados a su transmisión en gestantes. Centro de investigación educación y servicios de salud, Santa Cruz de la Sierra. Rev Enferm Infecc Trop 2009;1(1):44-8.
Frenkel JK, Friedlander S. Toxoplasmosis: patología de la enfermedad neonatal, patogénesis, diagnóstico y tratamiento 1951. Washington (DC): Oficina de Imprenta del Gobierno de EE.UU. Servicio de Salud Pública de EE. UU; 1951. Publicación No. 141.
Asriztia A, Martínez F, Howard J, Latorre M. Toxoplasmosis con natal activa en un recién nacido con demostración del parasito in vivo. Rev Chil Pediatr 1954;25:11-2: DOI https://doi.org/10.4067/S0716-10182015000600008
Jefferson E. Clears first test for recent infection with toxoplasmosis parasite, FDA U.S. Food and Drug Administration 2011;301796-4988. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm255922.htm
Apt W, Thiermann E, Niedmann G, Pasmanik S. Toxoplasmosis. Departamento de Microbiología y parasitología, Unidad de Parasitología, Facultad de Medicina, Universidad de Chile. Colección de monografías biológicas de la universidad de Chile, Chile 1973: DOI https://doi.org/10.4067/S0716-10182015000600008
Roca García M, Camacho Gambá J, Esguerra GG. Un caso de toxoplasmosis congénita. Rev Colomb Pediatr Pueric 1951;10:238-76.
Oropeza P, Raga Mendoza M. La toxoplasmosis humana en Venezuela. Rev Colomb Pediatr Pueric 1953;12(4):255-9.
Weiss LM, Dubey JP. Toxoplasmosis a history of clinical observations. Int J Parasitol 2009;39(8):895-901 DOI: https://doi.org/10.4067/S0716-10182015000600008
Desmonts G, Couvreur J. Congenital toxoplasmosis. A prospective study of 378 pregnancies. N Engl J Med 1974;290(20):1110-6. DOI: https://doi.org/10.1056/NEJM197405162902003
Sabin AB, Feldman HA. Dyes as microchemical indicators of a new immunity phenomenon affecting a protozoon parasite (Toxoplasma). Science 1948;10;108(2815):660-3. DOI: https://doi.org/10.1126/science.108.2815.660
Holland GN, Engstrom RE, Glasgow BJ, Berger BB, Daniels SA, Sidikaro Y, et al. Ocular toxoplasmosis in patients with the acquired immunodeficiency syndrome. Am J Ophtalmol 1988;106(6):653-67.
Izaguirre L, Gonzalvo FJ, Ferrer E, Honrubia FM. Edema macular quístico por Toxoplasma gondii. Arch Soc Canar Oftal 2000;11:95-9.
Díaz Suarez O, Estévez J, García M, Cheng Ng R, Araujo J, García M. Seroepidemiologia de la toxoplasmosis en una comunidad indígena Yucpa de la Sierra de Perijá, Estado Zulia, Venezuela. Rev Med Chile 2003;131(9):1003-10.
Lee YF, Chen SJ, Chung YM, Liu JH, Wong WW. Diffuse toxoplasmic retinochoroiditis as the initial manifestation of acquired immunodeficiency syndrome. J Formos Med Asoc 2000;99(3):219-23.
Klaren VN, Kijlstra A. Toxoplasmosis, an overview with emphasis on ocular involvement. Ocul Immunol Inflamm 2002;10(1):1-26. DOI: https://doi.org/10.1076/ocii.10.1.1.10330
Shin DW, Cha DY, Hua QJ, Cha GH, Lee YH. Seroprevalence of Toxoplasma gondii infection and characteristics of seropositive patients in general hospitals in Daejeon, Korea. Korean J Parasitol 2009;47(2):125-30. DOI: https://doi.org/10.3347/kjp.2009.47.2.125
Xiao Y, Yin J, Jiang N, Xiang M, Hao L, Lu H, et al. Seroepidemiology of human Toxoplasma gondii infection in China. BMC Infect Dis 2010;10:4. DOI: https://doi.org/10.1186/1471-2334-10-4
Kamani J, Mani AU, Egwu GO, Kumshe HA. Seroprevalence of human infection with Toxoplasma gondii and the associated risk factors, in Maiduguri, Borno state, Nigeria. Ann Trop Med Parasitol 2009;103(4):317-21. DOI: https://doi.org/10.1179/136485909X435094
Swai ES, Schoonman L. Seroprevalence of Toxoplasma gondii infection amongst residents of Tanga district in northeast Tanzania. Tanzan J Health Res 2009;11(4):205-9. DOI: https://doi.org/10.4314/thrb.v11i4.50178
Fromont EG, Riche B, Rabilloud M. Toxoplasma seroprevalence in a rural population in France: Detection of a household effect. BMC Infect Dis 2009;9:76. DOI: https://doi.org/10.1186/1471-2334-9-76
Punda Polić V, Tonkić M, Capkun V. Prevalence of antibodies to Toxoplasma gondii in the female population of the Country of Split Dalmatia, Croatia. Eur J Epidemiol 2000;16(9):875-7. DOI: https://doi.org/10.1023/a:1007606501923
Jeannel D, Niel G, Costagliola D, Danis M, Traore BM, Gentilini M. Epidemiology of toxoplasmosis among pregnant women in the Paris area. Int J Epidemiol 1988;17(3):595-602. DOI: https://doi.org/10.1093/ije/17.3.595
Decavalas G, Papapetropoulou M, Giannoulaki E, Tzigounis V, Kondakis XG. Prevalence of T. gondii antibodies in gravidas and recently aborted women and study of risk factors. Eur J Epidemiol 1990;6(2):223-6. DOI: https://doi.org/10.1007/BF00145798
Alvarado Esquivel C, Sifuentes Álvarez A, Narro Duarte SG, Estrada Martínez S, Díaz García JH, Liesenfeld O, et al. Seroepidemiology of Toxoplasma gondii infection in pregnan women in a public hospital in northern Mexico. BMC Infect Dis 2006;6:113. DOI: https://doi.org/10.1186/1471-2334-6-113
Stillwaggon E, Carrier C, Sautter M, McLeod R. Maternal serologic screening to prevent congenital toxoplasmosis: a decision-analytic economic model. PLoS Negl Trop Dis 2011;5(9):e1333. DOI: https://doi.org/10.1371/journal.pntd.0001333
Ramsewak S, Gooding R, Ganta K, Seepersadsingh N, Adesiyun AA. Seroprevalence and risk factors of Toxoplasma gondii infection among pregnant women in Trinidad and Tobago. Rev Panam Salud Publica 2008; 23(3): 164-70. DOI: https://doi.org/10.1590/s1020-49892008000300003
Jones JL, Kruszon Moran D, Wilson M, McQuillan G, Navin T, McAuley JB. Toxoplasma gondii infection in the United States: Seroprevalence and risk factors. Am J Epide-miol 2001;154(4):357-65. DOI: https://doi.org/10.1093/aje/154.4.357
Barbosa IR, de Carvalho Xavier Holanda CM, de Andrade-Neto VF. Toxoplasmosis screening and risk factors amongst pregnant females in Natal, northeastern Brazil. Trans R Soc Trop Med Hyg 2009;103(4):377-82. DOI: https://doi.org/10.1016/j.trstmh.2008.11.025
Juliao O, Corredor A, Moreno GS. Toxoplasmosis en Colombia. Estudio Nacional de Salud. Bogotá: Instituto Nacional de Salud 1988. En: Gómez JE, editor. Evaluación del tratamiento de la toxoplasmosis gestacional en una cohorte colombiana. Infectio 2005;9:16-23.
Jones JL, Kruszon Moran D, Sanders Lewis K, Wilson M. Toxoplasma gondii infection in the United States, 1999-2004, decline from the prior decade. Am J Trop Med Hyg 2007;77(3):405-10. DOI: https://doi.org/10.4269/ajtmh.14-0013
Jones JL, Holland GN. Annual burden of ocular toxoplasmosis in the US. Am J Trop Med Hyg 2010;82(3):464-5. DOI: https://doi.org/10.4269/ajtmh.2010.09-0664
Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson MA, Roy SL, et al. Foodborne illness acquired in the United States major pathogens. Emerg Infect Dis 2011;17(1):7-15. DOI: https://doi.org/10.3201/eid1701.p11101
Khan A, Fux B, Su C, Dubey JP, Darde ML, Ajioka JW, et al. Recent transcontinental sweep of Toxoplasma gondii driven by a single monomorphic chromosome. Proc Natl Acad Sci USA 2007;104(37):14872-7. DOI: https://doi.org/10.1073/pnas.0702356104
Mercier A, Devillard S, Ngoubangoye B, Bonnabau H, Bañuls AL, Durand P, et al. Additional haplogroups of Toxoplasma gondii out of Africa: population structure and mouse-virulence of strains from Gabon. PLoS Negl Trop Dis 2010;4(11):e876. DOI: https://doi.org/10.1371/journal.pntd.0000876
Khan A, Jordan C, Muccioli C, Vallochi AL, Rizzo LV, Belfort R Jr, et al. Genetic divergence of Toxoplasma gondii strains associated with ocular toxoplasmosis, Brazil. Emerg Infect Dis 2006;12(6):942-9. DOI: https://doi.org/10.3201/eid1206.060025
Iihoshi Nm Gianella A. Toxoplasmosis en un grupo de estudiantes de Santa Cruz de la Sierra. Bol Cient CENETROP 1997;16(1):46-8.
Minot S, Melo MB, Li F, Lu D, Niedelman W, Levine SS, et al. Admixture and recombination among Toxoplama gondii lineages explain global genome diversity. Proc Natl Acad Sci USA 2012;109(33):13458-63. DOI: https://doi.org/10.1073/pnas.1117047109
Pelloux H, Brenier Pinchart MP, Fricker Hidalgo H. Protozoan infections in humans: congenital toxoplasmosis. Eur J Protistol 2003;39(4):444-8. DOI: https://doi.org/10.1078/0932-4739-00018
Lou P, Kazdan J, Basu PK. Ocular toxoplasmosis in three consecutive siblings. Arch Ophthalmol 1978;96(4):613-4. DOI: https://doi.org/10.1001/archopht.1978.03910050309001
Asbell PA, Vermund SH, Hofeldt AJ. Presumed toxoplasmic retinochoroiditis in four siblings. Am J Ophthalmol 1982;94(5):656-63. DOI: https://doi.org/10.1016/0002-9394(82)90011-3
Ladas ID, Rallatos CL, Kanaki CS, Damanakis AG, Zafirakis PK, Rallatos G. Presumed congenital ocular toxoplasmosis in two successive siblings. Ophthalmological 1999;213(5):320-2. DOI: https://doi.org/10.1159/000 027446
Ohl C, Dornier L, Czajka C, Chobaut JC, Tavernier L. Newborn hearing screening on infants at risk. Int J Ped Otorhinolaryngol 2009;73(12):1691-5. DOI: https://doi.org/10.1016/j.ijporl.2009.08.027
Prandota J. Autism spectrum disorders may be due to cerebral toxoplasmosis associated with chronic neuroinflammation causing persistent hypercytokinemia that resulted in an increased lipid peroxidation, oxidative stress, and depressed metabolism of endogenous and exogenous substances. Research in Autism Spectrum Disorders. 2010;4(2):119-55. DOI: https://doi.org/10.1016/j.rasd.2009.09.011
Freeman K, Oakley L, Pollak A, Buffolano W, Petersen E, Semprini AE, et al. Association between congenital toxoplasmosis and preterm birth, low birthweight and small for gestational age birth. Int J Gynecol Obstet 2005;112(1):31-7. DOI: https://doi.org/10.1111/j.1471-0528.2004.00299.x
Elwakil HS, Abdel Hameed DM, Thabet HS, Ahmed MA. Detection of molecular markers of toxoplasmosis among Egyptian patients with miscarriage using avidity IgG-Elisa and Western blotting. J Egypt Soc Parasitol 2008;38(2):537-46.
Rorman E, Zamir CS, Rilkis I, Ben David H. Congenital toxoplasmosis prenatal aspects of Toxoplasma gondii infection. Reprod Toxicol 2006;21(4):458-72. DOI: https://doi.org/10.1016/j.reprotox.2005.10.006
Viso RA, Zighelboim I, Maekelt A. Evaluación de la intradermorreacción con toxoplasmina. Rev Obstet Ginecol Venez 1965;25:535-53.
Garweg JG, Scherrer J, Wallon M, Kodjikian L, Peyron F. Reactivation of ocular toxoplasmosis during pregnancy. Int J Gynecol Obstet 2005;112(2):241-2. DOI: https://doi.org/10.1111/j.1471-0528.2004.00302.x
Dunn D, Newell ML, Gilbert R. Low risk of congenital toxoplasmosis in children born to women infected with human immunodeficiency virus. Pediatr Infect Dis J 1997;16(1):84.
Romand S, Wallon M, Franck J, Thulliez P, Peyron F, Dumon H. Prenatal diagnosis using polymerase chain reaction on amniotic fluid for congenital toxoplasmosis. Obstet Gynecol 2001;9782):296-300. DOI: https://doi.org/10.1016/s0029-7844(00)01118-2
Remington JS, Thulliez P, Montoya JG. Recent developments for diagnosis of toxoplasmosis. J Clin Microbiol 2004;4283):941-5. DOI: https://doi.org/10.1128/jcm.42.3.941-945.2004
Romand S, Chosson M, Franck J, Wallon M, Kieffer F, Kaiser K, et al. Usefulness of quanti-tative polymerase chain reaction in amniotic fluid as early prognostic marker of fetal infection with Toxoplasma gondii. Am J Obstet Gynecol 2004;190(3):797-802. DOI: https://doi.org/10.1016/j.ajog.2003.09.039
Montoya JG. Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis. J Infect Dis 2002;185(Suppl 1):S73-82. DOI: https://doi.org/10.1086/338827
Hohlfeld P, Daffos F, Thulliez P, Aufrant C, Couvreur J, MacAleese J, et al. Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment. J Pediatr 1989;115(5 Pt 1):765-9. DOI: https://doi.org/10.1016/s0022-3476(89)80660-2
Hohlfeld P, Mac Alesse J, Capella Pavlovski M, Giovangrandi Y, Thulliez P, Forestier F, et al. Fetal toxoplasmosis: ultrasonographic signs. Ultrasound Obstet Gynecol 1991;1:241-4. DOI: https://doi.org/10.1046/j.1469-0705.1991.01040241.x
Couvreur J, Thulliez P, Daffos F, Aufrant C, Bompard Y, Gesquiere A, et al. Fetal toxoplasmosis. In utero treatment with pyrimethamine sulfamides. Arch Fr Pediatr 1991;48(6):397-403.
Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004;363(9425):1965-76. DOI: https://doi.org/10.1016/S0140-6736(04)16412-X
Remington JS, McLeod R, Thulliez P, Desmonts G. Toxoplasmosis. In: Remington JS, Klein J, editors. Infectious diseases of the fetus and newborn infant. 6th ed. Philadelphia: WB Saunders; 2006. p. 947-1092.
Campello Porto L, Duarte EC. Association between the risk of congenital toxoplasmosis and the classification of toxoplasmosis in pregnant women and prenatal treatment in Brazil, 1994-2009. Int J Infectio Dis 2012;16(7):e480-6. DOI: https://doi.org/10.1016/j.ijid.2012.01.016
Robert Gangneux F, Murat JB, Fricker Hidalgo H, Brenier Pinchart MP, Gangneux JP, Pelloux H. The placenta: a main role in congenital toxoplasmosis? Trends Parasitol 2011;27(12):530-6. DOI: https://doi.org/10.1016/j.pt.2011.09.005
Dardé ML, Peyron F. Toxoplasma y toxoplasmosis. EMC Pediatría 2013;48(1):1-12. DOI: https://doi.org/10.1016/S1245-1789(13)64153-0
Ocampo LM, Duarte Gandica I. A model of congenital toxoplasmosis transmission dynamics. Rev Salud Pública 2010;12(2):317-26.
Peyron F, Wallon M, Liou C, Garner P. Treatments for toxoplasmosis in pregnancy. Cochrane Database of Systematic Reviews 1999;(3): CD001684. DOI: https://doi.org/10.1002/14651858.CD001684
Saghrouni F, Khammari I, Ben Abdeljelil J, Yaacoub A, Gaïed Meksi S, Ach H, et al. Congenital toxoplasmosis: Series of 21 cases. J de Pediatrie y de Puericur J 2013;26(2):83-9. DOI: https://doi.org/10.1016/j.jpp.2013.01.004
Elmore SA, Jones JL, Conrad PA, Patton S, Lindsay DS, Dubey JP. Toxoplasma gondii: epidemiology, feline clinical aspects, and prevention. Trends Parasitol 2010;26(4):190-6. DOI: https://doi.org/10.1016/j.pt.2010.01.009
Jiang W, Sullivan AM, Su C, Zhao X. An agent-based model for the transmission dynamics of Toxoplasma gondii. J Theor Bio 2012;293:15-26. DOI: https://doi.org/10.1016/j.jtbi.2011.10.006
Gómez Marín JE, de la Torre A, Ángel Müller E, Rubio J, Arenas J, Osorio E, et al. First Colombian metacentric newborn screening for congenital toxoplasmosis. PLoS Negl Trop Dis 2011;5(5):e1195. DOI: https://doi.org/10.1371/journal.pntd.0001195
Friedmann CT, Knox DX. Variations in recurrent active toxoplasmic retinochoroiditis. Arch Ophthalmol 1969;81(4):481-3. DOI: https://doi.org/10.1001/archopht.1969.00990010483005
Dodds EM, Holland GN, Stanford MR, Yu F, Siu WO, Shah KH, et al. Intraocular inflammation associated with ocular toxoplasmosis: relationships at initial examination. Am J Ophthalmol 2008;146(6):856-65.e2. DOI: https://doi.org/10.1016/j.ajo.2008.09.006
Pleyer U, Torun N, Liesenfeld O. Ocular toxoplasmosis. Ophthalmologe 2007;104(7): 603-15. DOI: https://doi.org/10.1007/s00347-007-1535-8
Dubey JP. Toxoplasmosis of animals and humans. Second Edition. Florida: CRC Press, Boca Raton;2009.
Gilbert R. Epidemiology of infection in pregnant women. In: Ambroise Thomas P, Petersen E, editors. Congenital toxoplasmosis. Scientific background, clinical management and control. Paris: Springer-Verlag; 2000. p. 237-49.
Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, Gilbert R. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counseling. Lancet 1999;353(9167): 1829-33. DOI: https://doi.org/10.1016/S0140-6736(98)08220-8
Wilson CB, Remington JS, Stagno S, Reynolds DW. Development of adverse in children born with subclinical congenital Toxoplasma infection. Pediatrics 1980;66(5):767-74.
Patel DV, Holfels EM, Vogel NP, Boyer KM, Mets MB, Swisher CN, et al. Resolution of intracraneal calcifications in infants with treated congenital toxoplasmosis. Radiology 1996;19982):433-40. DOI: https://doi.org/10.1148/radiology.199.2.8668790
Dubey JP, Karhemere S, Dahl E, Sreekumar C, Diabaté A, Dabiré KR, et al. First biologic and genetic characterization of Toxoplasma gondii isolates from chickens from Africa (Democratic Republic of Congo, Mali, Burkina Faso, and Kenya). J Parasitol 2005;91(1):69-72. DOI: https://doi.org/10.1645/GE-410R
McAuley J, Boyer K, Patel D, Mets M, Swisher C, Roizen N, et al. Early and longitudinal evaluations of treated infants and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial. Clin Infect Dis 1994;19(4):820. DOI: https://doi.org/10.1093/clinids/18.1.38
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Current Opinion Nursing & Research
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
